Related references
Note: Only part of the references are listed.Type 2 Gaucher disease: Phenotypic variation and genotypic heterogeneity
N. Gupta et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
New insights in gene-derived therapy: the example of Duchenne muscular dystrophy
Annemieke Aartsma-Rus et al.
YEAR IN HUMAN AND MEDICAL GENETICS: NEW TRENDS IN MENDELIAN GENETICS (2010)
Evolution of biomarker qualification at the health authorities
Federico Goodsaid et al.
NATURE BIOTECHNOLOGY (2010)
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium
Frank Dieterle et al.
NATURE BIOTECHNOLOGY (2010)
Biomarkers in oncology drug development
Darren R. Hodgson et al.
MOLECULAR ONCOLOGY (2009)
Gene therapy progress and prospects: Duchenne muscular dystrophy
K. Foster et al.
GENE THERAPY (2006)
Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading-frame rule
Annemieke Aartsma-Rus et al.
MUSCLE & NERVE (2006)
Aspects of molecular phenotype and its correlations with breast cancer behaviour and taxonomy
AM Hanby
BRITISH JOURNAL OF CANCER (2005)
Enzyme replacement in Gaucher disease
E Beutler
PLOS MEDICINE (2004)
Share Paper
